Sodium Oxybate Extended Release Oral Suspension (Avadel Pharmaceuticals)

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameSodium Oxybate Extended Release Oral Suspension (Avadel Pharmaceuticals)
Drug Alias NameMicropump Sodium OxybateLUMRYZON-SXBFT-218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSleepinessCataplexyNarcolepsy +[8] 
Global Approved IndicationsSleepinessCataplexy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/05/01
Country/TerritoryCzechiaCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAvadel Pharmaceuticals Plc
China Registration ClassN/A

Develop Information

Active CompaniesAvadelAvadel Cns Pharmaceuticals LlcAvadel Pharmaceuticals Plc +[5] 
Inactive CompaniesN/A
Active IndicationsSleepinessCataplexyNarcolepsy +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A